Takeda to discontinue trial in AL Amyloidosis

Takeda Pharmaceutical Company Limited has announced that the Phase 3 TOURMALINE-AL1 clinical trial in patients with...

June 6, 2019 | Thursday | News
A unique solution to boost immunization in developing countries

Gavi, the Vaccine Alliance, NEC Corporation, and Simprints Technology Ltd. have signed a memorandum of understanding on ...

June 10, 2019 | Monday | News
Otsuka Chemical acquires Cefixime business of Astellas Pharma

Otsuka Chemical Co., Ltd has announced its acquisition on cefixime business from Astellas Pharma, Inc. on 5 June 2019,...

June 10, 2019 | Monday | News
PeptiDream announces strategic partnership with drug-delivery expert PharmaIN

PeptiDream Inc., a public Kanagawa-based biopharmaceutical company, on 5 June 2019, announced a strategic partnership wi...

June 6, 2019 | Thursday | News
LPIXEL announces initiation of AI System development for cell evaluation with Astellas Pharma

LPIXEL Inc., a leader in image analysis and processing technology in life science and medical research has announced the...

June 5, 2019 | Wednesday | News
Takeda Makes First Private Sector Pledge for Global Fund Replenishment

Takeda Pharmaceutical have became the first private sector company to announce a financial commitment to the Global Fund...

June 4, 2019 | Tuesday | News
Thermo Fisher receives reimbursement coverage for Oncomine test

Thermo Fisher Scientific has announced that its Oncomine Dx Target Test CDx System has received reimbursement coverage f...

June 4, 2019 | Tuesday | News
World's First Digital nicotine-dependent Treatment App from CureApp for higher sustained smoking cessation (CAR) rate

The CureApp nicotine-dependent treatment app is clinically proved as a higher rate of sustained smoking cessation (CAR) ...

June 3, 2019 | Monday | News
Scientists bioengineer human liver disease in the lab

Scientists successfully bioengineered human liver organoids that faithfully mimic key features of fatal liver disease in...

May 31, 2019 | Friday | News
Beam Therapeutics, Bio Palette to develop microbiome-related therapeutics in Asia

Beam Therapeutics and Bio Palette have announced an exclusive cross-license agreement around each companies’ base ...

June 3, 2019 | Monday | News
PENTAX Medical launches MILES FOR HEALTH(TM) campaign

PENTAX Medical, a leading provider of endo-imaging solutions, will soon celebrate the 100th anniversary of the foundatio...

May 30, 2019 | Thursday | News
Hitachi signs contract with HIMED to Deliver Particle Therapy System

Japanese multinational conglomerate company Hitachi has signed a contract with Himed Hospital Management (Xuzhou) C...

May 31, 2019 | Friday | News
Chugai Pharma aims to create high quality innovative drugs

Japanese firm Chugai Pharmaceutical Co., Ltd. has announced the decision to construct a core research laboratory, C...

May 30, 2019 | Thursday | News
Scientists develop technique for better detection of breast cancer

Researchers at Okayama University report in the journal Sensors and Actuators B: Chemical that terahertz radia...

May 24, 2019 | Friday | News
Menicon launches holistic approach for myopia control management

Japan headquartered Menicon Co. has announced the launch of the Menicon Bloom Myopia Control Management System...

May 28, 2019 | Tuesday | News
B dot Medical to develop ultra-compact proton cancer therapy

Japan based B dot Medical Inc. has announced that the company has initiated the development of an ultra-compact pro...

May 28, 2019 | Tuesday | News
Chugai’s Actemra Intravenous Infusion receives additional approval for Adult Still’s Disease

Chugai Pharmaceutical has announced that it has obtained regulatory approval for the humanized anti-human IL-6 receptor ...

May 24, 2019 | Friday | News
Japan approves use of Elekta Unity MRI therapy system

Elekta (EKTA-B.ST) has announced that its Elekta Unity magnetic resonance radiation therapy system has been approved for...

May 24, 2019 | Friday | News